Will investments in biobanks, prospective cohorts, and markers of common patterns of variation benefit other populations for drug response and disease susceptibility gene discovery?
Foster
M W
MW
Department of Anthropology, University of Oklahoma, Norman, OK 73019, USA. morris.w.foster-1@ou.edu
Sharp
R R
RR
D015331:Cohort Studies; D030541:Databases, Genetic; D015195:Drug Design; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D014644:Genetic Variation; D006801:Humans; D010641:Phenotype; D011153:Population; D011446:Prospective Studies
D005819:Genetic Markers